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Abstract 
 
The cardiac late sodium current (INa,L) has been in the focus of research in the last decade. The first 
reports on the sustained component of voltage activated sodium current dates back to the early 
seventies, but early observations interpreted this tiny current as a product of a few channels that fail to 
inactivate having neither physiologic nor pathologic implications. INa,L has emerged recently as a 
potentially major arrhythmogenic mechanism in various heart diseases attracting the attention of both 
clinicians and researchers. Research activity on INa,L  has exponentially increased since Ranolazine, an 
FDA-approved antianginal drug was shown to successfully suppress cardiac arrhythmias by inhibiting 
INa,L. This review aims to conclude a series of papers concerned with physiology and regulation of cardiac 
late sodium current. Focusing on some recent development of the field we discuss here critical 
evidences implicating INa,L as a potential target for treating myocardial dysfunction and cardiac 
arrhythmias. 
 
 
1. INTRODUCTION 
Cardiac arrhythmias are the primary cause of death and a major public health problem. However, anti-
arrhythmic drug therapies using ion channel blockers led to conflicting results. Many seemingly 
promising drugs turned out to be proarrhythmic.  Clinical experiences by many physicians sum up to 
two important observations: (1) Ion channels blockers are risky, and some exacerbate arrhythmias.  (2) 
Relatively successful drugs, such as beta blockers and amiodarone, modulate not only ion channels but 
also Ca2+ homeostasis. Implantable cardioverters and catheter ablation opened a new dimension in the 
reduction of arrhythmia related mortality. However, these techniques, being introduced during the last 
decade, are not widely applicable in several cases of life threatening arrhythmias, therefore, 
pharmacological therapy remained the most frequently applied medical intervention in controlling 
arrhythmias. 
The tiny sustained part of sodium current termed as late sodium current (INa,L) was out of the focus of 
research for long time but immediately attained increasing interest since it was linked to cardiac 
diseases. Upregulation of the plateau sodium current has been implicated in multiple inherited or 
acquired arrhythmia syndromes or structural heart diseases. In the same time, inhibition of the currents 
was demonstrated to prevent or reduce arrhythmic activity in multiple pathologic models.  
Exponentially increasing number of research publications and comprehensive reviews [1-6] published in 
the last few years indicate the great expectation on INa,L as a new, potential therapeutic target. At the 
present, one of the greatest limiting factors that delay the progress of the field is the lack of specific INa,L 
inhibitors.  Developing highly specific INa,L blockers would facilitate research and could provide 
archetype for a new class of antiarrhythmic drugs.  
 
 
2. Brief historical remarks on cardiac late sodium current 
Dubois and Bergman reported their observations on a persistent, tetrodotoxin (TTX) sensitive current 
present in frog Ranvier node in 1975. The current was interpreted as a fraction of voltage activated 
sodium current that failed to inactivate [7]. The concept of INa,L has been established with this 
publication. Four years later Coraboeuf et al. observed that low concentration of TTX shortened canine 
Purkinje AP without reducing the amplitude of ‘the normal rapid sodium current’ [8]. The authors 
suggested two critical features for INa,L in their publication: a) there is a sodium current flowing during 
entire plateau of cardiac AP b) involvement of non-cardiac voltage dependent sodium channels. In 
accordance with these results Attwell et al. reported the presence of a TTX sensitive non inactivating 
sodium current at negative membrane potentials in sheep Purkinje fibers [9]. They suggested that 
window mechanism is involved in generation of sustained sodium current and predicted that this 
current might have large effect on AP duration. Ten years later Kiyosue and Makita conducted a 
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systematic study on the plateau sodium current in guinea pig ventricular cells [10]. They identified three 
different types of sodium channel activities, two of them present longer than 100 ms following 
depolarization, thus casted as ‘late’ activity. They characterized both a ‘late scattered mode’ and ‘burst 
mode’ known to be responsible for INa,L (discussed later) and showed the ‘normal’ (today: transient) 
channel activation is followed by late activity in less than 4% of patches. They confirmed Coraboeuf et 
al.’s observation on the AP shortening effect of TTX and suggested INa,L contributes to regulation of the 
AP length. The central question in these early years was whether this relatively small current can play a 
significant role in shaping the AP or not. In the following years INa,L was shown to be upregulated by 
hypoxia, free radicals or ischemic metabolites  [11-13]. The finding that elevated plateau current was 
linked to cardiac diseases especially to an increased propensity of arrhythmias gave a huge boost to INa,L 
research [14-17]. Recent experimental evidences obtained by modern electrophysiology technique 
indicated that earlier observations made under equilibrium voltage conditions significantly 
underestimated the magnitude of INa,L [18, 19]. When INa,L is measured by self action potential clamp 
method, the magnitude of the current is comparable with that of major potassium currents making it a 
cardinal player in shaping AP [20]. 
 
3. The identity of sustained plateau sodium current: one current 
with multiple mechanisms? 
Mammalian cells express several isoforms of voltage-dependent sodium channels distinguishable by 
their kinetics, unit conductance and drug sensitivity. The dominant isoform in cardiac tissues is referred 
as Nav1.5 and characterized by relative insensitivity to tetrodotoxin, saxitoxin and µ-conotoxin [21, 22]. 
Alternative names for this channel encoded by the gene SCN5A are h1 or skm II channels. The pore 
forming, large α subunit is associated with four auxiliary ß1through ß4 subunits which are known to 
modify the kinetics and voltage dependence of the channel. Under resting membrane potential 
conditions the channel is in non-conductive state, but sufficient depolarization (V1/2: -40/-50 mV) 
activates the channel and shifts it to conductive state [23-25]. 
 
3.1. Different channel activity patterns may contribute to INa,L   
Upon changes of membrane potential sodium channels undergo a sequence of conformational changes. 
Following significant depolarization the majority of closed channels opens in less than two milliseconds 
then inactivates within two ms too [26, 27]. Transition from inactivation to closed state is promoted by 
repolarization. If membrane remains depolarized the first opening can be followed by several 
reopening. Maltsev & Undrovinas studying single human cardiac sodium channels observed and 
modelled three distinct types of activity present in human ventricular myocytes [28]. In Transient Mode 
(TM) the first opening is followed by 5-10 rapid reopening resulted by flip-flops between open and 
inactive state of the channel (Figure 1). This repetitive activity is terminated within less than 40 ms 
when channel is absorbed in a second inactive state resulting in rapid decline of ensemble current. The 
current magnitude drops below 10% of the peak within 3 ms. The contribution of TM to peak sodium 
current is ~90%, but 20 ms later it represents less than 1% of the total INa. This gating mode alone 
adequately reproduces the transient phase (0-5 ms) of INa but fails to explain the sustained component 
seen during the AP plateau. The second gating mode that contributes to the early phase or Burst Mode 
(BM) is characterized by sustained openings with brief closing periods (Figure 1). Increased transition 
rate from inactivated to open state and reduced probability toward absorbing second inactivated state 
results in long lasting (100-300 ms) activity before terminated by the absorbing state. These non-
inactivating bursts has been already known from both skeletal and cardiac muscle and were referred as 
slow, non-inactivating, or “cloudburst” currents [29-31]. Facilitation of BM were reported from cardiac 
muscles after chemical intervention and termed ‘failure of inactivation’ [32]. Channels display BM at 
very low probability generating only a tiny current. Hence, its contribution is negligible to INa,L during the 
first 2-5 ms following the upstroke. However, as the TM component of INa decays following the peak, the 
relative contribution of BM to total current can grow as high as 50%. BM current then declines and 200-
300 ms later it is replaced by the third gating mode referred as Late Scattered Mode (LSM). LSM can be 
derived from TM by reducing transition rates from inactive to open and second inactive (absorbing) 
state. It is characterized by sparse reopening for an extended period being as long as 500-1000 ms 
(Figure 1).  
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Figure 1. Schematic illustration for different channel activity patterns contributing to late sodium current. 
The involvement of the three different gating modes in INa changes dynamically during AP. Based on 
their contribution to sodium current it is possible to separate three phases or time period.  The early 
phase of AP (0-5 ms) is dominated exclusively by TM; BM and LSM are negligible. This is followed by an 
intermediate phase of AP (5-20 or 5-40 ms) where all three gating modes are present with steeply 
reducing weight of TM. The late phase of INa (referred as INa,L) starts 20-40 ms after the AP upstroke and 
maintained by BM and LSM. The contribution of BM and LSM to INa,L is equal at the  beginning of this 
phase, then monotonic reduction of BM leaves LSM the only gating mode shaping the plateau sodium 
current. Shifts in the relative magnitudes of the different gating modes caused by channel mutations or 
pathologic conditions have been implicated in cardiac electric disorders [33-42]. Targeted 
pharmacological modulation of different gating modes is hoped to exert cardioprotective and 
antiarrhythmic effects [43-45] . 
 
3.2. Window Currents 
The “window” region is the voltage range where the steady state activation and inactivation curves of 
sodium channels overlap. In the window region channels may recover from inactivation then reopen. 
This flip-flop between active and inactive states can provide a steady-state current if membrane 
potential is held within this sensitive voltage range. When identity of INa,L is discussed in the literature, 
the flip-flopping of the Na channel in the window region is usually the first mechanism used to explain 
the origin of sustained plateau sodium current [1-4]. The window mechanism seems like a plausible 
resolution to seemingly incompatible rapid inactivation of the sodium channels seen in voltage clamp 
experiments under rectangular command steps and the remarkably persistent sodium current during a 
several hundred milliseconds long AP plateau. However, while no experimental observation is known to 
question the existence of window mechanism, its contribution to INa,L might be limited because of the 
voltage range where plateau is found. The center of the window region occurs below -60 mV, far below 
the plateau voltage (about 0 mV) in most species reducing the probability for open state [2, 46]. 
Additionally, the current in the window region is very small in healthy conditions where the crossing 
point is less than 5% of the I/Imax [23, 46-48]. These two factors acting in synergism result in a small 
participation of window mechanisms to INa,L. Furthermore, experimental observations presented by 
Beyder et al.  indicate that shear stress shifts the window significantly to negative direction [49]. Since 
Closed
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our present knowledge on the position and with of window is based on electrophysiologic data obtained 
in unloaded cardiomyocytes, we can assume that the contribution of window to INa,L is even less than 
predicted by current models. Nevertheless, mutations or pathologic regulation of the channel might 
shift either steady state activation or inactivation curve altering the position and size of the window 
hence changing its contribution to INa,L [14].  
 
3.3. Non-equilibrium gating  
Different gating modes and the concepts of window current describe well the behavior of sodium 
current elicited with square pulses. However, when sodium channels are positioned in functioning 
cardiac cells they are exposed to dynamically changing voltage. Experimental data show that INa,L is 
facilitated when evoked with repolarizing voltage ramp or AP shape command [18-20]. Traditional 
Markovian models fail to reproduce this phenomenon, but Clancy et al. [18] proposed a new 
mechanism named ‘non-equilibrium gating’ that can explain these observations. According to this 
concept, recovery from inactivation is modulated by dynamically changing (non-equilibrium) voltage. 
The probability for reopening is increased during hyperpolarizing ramps resulting in facilitation of the 
activation transition. The most fascinating novelty in this hypothesis is that the transition rate from a 
given state is modulated by the voltage trajectory the channel experienced beforehand. Hence, kinetic 
parameters of the channel are influenced by its short-time history. Earlier models used simplified 
conditions and did include this ‘history factor’. Magyar et al. provided strong experimental evidence to 
support the non-equilibrium gating hypothesis. They demonstrated that opening probability of the 
sodium channel is higher during voltage ramp than that of observed with constant (rectangular) voltage 
command and sodium current duration depends on the duration of ramp [19]. Further, indirect 
evidence supporting this hypothesis were provided by Horvath et al. when they showed that the 
magnitude of INa,L is comparable with those of major potassium currents and the current profile is 
determined by the voltage profile of AP in ventricular myocytes [20]. These observation led them to the 
conclusion that non-equilibrium gating is the chief factor determining the profile of TTX sensitive 
current during AP [20]. Non-equilibrium gating theory does not preclude the involvement of other 
gating modes to INa,L. All the mechanisms discussed in this session might coexist and contribute to 
shaping the profile of sodium current during AP. Since different gating modes are assumed to have 
different drug sensitivities or affinities [43, 50, 51] understanding the mechanism behind INa,L  can help 
to develop new antiarrhythmic drugs or strategies. 
 
3.4. Non-cardiac sodium channels in the heart 
Association of ECG abnormalities to epilepsy [52, 53] and myotonic disorders [54, 55] raised the 
possibility that the same mutated sodium channels which are responsible for hereditary diseases of 
nervous system or skeletal muscles might cause repolarization abnormalities in the heart. Later, several 
‘non cardiac’ isoforms were identified in cardiac tissue by functional tests based on voltage dependency 
and drug sensitivity in different species [37, 56-58]. Using RT-PCR or immunocytochemistry the 
expression of Nav1.1, Nav1.2, Nav1.3, Nav1.4 and Nav1.6 were detected heart of multiple species [58-63]. 
According to the report of Westenbroek et al., non-cardiac isoforms represents a substantial fraction 
(23%) of the total number of sodium channels in mouse heart [60]. Moreover, the distribution of 
different isoforms show characteristic patterns. While the cardiac isoform Nav1.5 is localized 
preferentially to the sarcolemma including intercalated disks is absent from T-tubules, Nav1.1 and 
Nav1.3 (non-cardiac) isoforms are found to be localized to the T-tubules and absent from the cell 
surface. Nav1.4 and Nav1.6 showed low level surface staining. These data indicate that cardiac and non-
cardiac isoforms of sodium channels have different role in the electrical excitation of cardiac cells. While 
the cardiac isoform is likely responsible for the cell-to-cell propagation of electric signal, the primary 
role of non-cardiac isoforms is to couple the electric signal to calcium dynamics [59, 60]. This sharp 
functional distinction might be questioned by earlier work of Malhotra et al. who observed 
colocalization of Nav1.1 and Nav1.5 isoforms in rat myocardium [64]. 
The presence of non-cardiac isoforms in cardiac muscle naturally raises the question: what is the 
contribution of these non-cardiac sodium channels to total sodium current, especially to INa,L? Biet et al. 
addressed this question and the data they presented suggests that the contribution of non-cardiac 
sodium channels to the peak INa is between 5-10%, but 44% of INa,L is generated by non-cardiac isoforms 
[56]. This observation has been confirmed by Yang et al. reporting that Nav1.8 provide the 38% of INa,L 
[57]. Considering the different kinetics, voltage and drug sensitivity of cardiac and non-cardiac voltage 
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regulated sodium channels, as well as the distinct localization of different isoforms within the cardiac 
cell, these observations open a new direction in the exploration of physiological and pathological roles 
of INa,L. Research for isoform specific sodium channel inhibitors might establish a new strategy in 
antiarrhythmic therapy. 
 
4. The Physiology of plateau sodium current 
Several membrane currents delicately shape the plateau of cardiac action potential. To understand the 
interplay of currents and voltage during the plateau phase it is important to note that (1) the currents 
flowing in this phase are small relative to those that govern the upstroke and terminal repolarization, (2) 
the algebraic sum of the currents is small. The latter accounts for dV/dt being close to zero [65]. 
Because the magnitudes of the currents are inherently small, even subtle changes in any current can 
have a large impact on AP morphology. Additionally, the plateau currents IKr and IKs are sensitive to 
changes in membrane voltage near the plateau voltage. This synergistic interplay between currents and 
voltage during the plateau have significant impact on the time course of terminal repolarization, thus 
duration of the AP [66].  
 
4.1. Contribution of plateau sodium current to cardiac electric activity  
Most of our current knowledge on the electrophysiology of INa,L originates from experiments employing 
rectangular voltage command and computer simulations based on these data. These results predicted a 
tiny flat current present during the whole length of AP. The extent of contribution of INa,L to shaping AP 
under physiologic conditions was a subject of debate because of its small magnitude. Nevertheless two 
complementary lines of experimental evidence indicated that the plateau sodium current affected the 
AP. First, TTX block shortened the AP [8, 10] and second, facilitation of INa,L lengthened the AP [20, 67]. 
Furthermore, an increasing number of observations indicate that the magnitude of INa,L was markedly 
underestimated in earlier reports. When using ramp or AP shape command, there is a substantial 
increase in current magnitude [18, 19]. Recent publication employing self-action potential technique 
indicates that the magnitude of the current during plateau is comparable to those of delayed potassium 
currents [20]. 
We have only a small number of reports displaying direct recording if INa,L during AP where the late 
component is not distinguishable from the early, transient phase. When cardiac sodium current is 
measured by rectangular command, it can be fitted by multiexponential function and the late 
component is a smooth continuation of the decaying early phase. When INa,L is recorded under AP 
command, there are two major type of profiles observed. In the first case the current magnitude decays 
monotonically; this profile was observed in dog and predicted by some of the models [68-70]. In the 
second type, the decay of transient phase is followed by a slow current accumulation during the 
plateau, then it forms a peak before the terminal repolarization of AP and declines rapidly reaching zero 
when membrane potential returns to resting level. This saddle-like profile was reported from human 
[71], canine [72], and guinea pig heart [20, 73]. These differences might arise from interspecies 
variances of AP shape, but the impact of methodological differences cannot be excluded either. 
INa is a key player in propagation of cardiac electric activation in the myocardium [63, 74] and in less 
extent to pacemaker activity especially in young age [75]. Due to the contribution of plateau sodium 
current to AP duration INa,L has strong influence in determining QT distance of the ECG. Increased INa,L is 
associated with lengthened QT interval (Long QT syndrome) and increased risk for arrhythmia [47, 76-
81]. In accordance with this, inhibiting INa,L was shown to shorten QT interval [82, 83]. Mutations 
resulting in facilitation of late sodium current are associated with increased QT dispersion too [52, 82]. 
How increased INa,L leads to increased QT dispersion is not completely understood, but transmural 
heterogeneity of sodium current is probably also involved [72, 84]. QT dispersion is determined 
routinely in clinical cardiology and regarded one of the most valuable predictor for arrhythmias [85, 86]. 
Thus, increased repolarization inhomogeneity due to pathologic INa,L might be the substrate for 
arrhythmias caused by sodium channel mutations. Other forms of electric disturbances are also linked 
to pathologic sodium channel function such as  Brugada syndrome [15, 87-92], slow impulse 
propagation [23, 93, 94], familiar atrial fibrillation [95, 96] and sick sinus syndrome [97, 98]. Cases, 
where sodium channel mutations were associated with cardiomyopathy were reported often with 
electric disturbances [99-101]. The link between altered channel function and structural diseases has 
not been established. However, these cases indicate that altered ionic balance may lead to structural 
heart diseases via modulation of genetic regulation. 
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4.2. Transmural heterogeneity of INa,L  
It is well known that transmural differences in densities of cardiac ionic currents and AP shape are 
present in ventricles [102-105]. Differences in sodium current magnitude between epicardial and 
endocardial cells were also observed in canine and murine heart [72, 84, 106]. According to these 
reports INa,L is larger in M cells than in the epicardial or endocardial region of canine ventricular wall 
contributing to the transmural differences in AP parameters. M cells are also known to display steeper 
rate dependence of AP than either epicardial or endocardial cells [107-109]. This coincidence might 
indicate significant contribution of INa,L to rate adaptation of AP length. This hypothesis is supported by 
earlier observations of Nuyens et al. who reported that increased INa,L results in increased lengthening of 
AP duration at low pacing rate [110]. The issue was addressed by Guo et al. in a systematic study where 
they demonstrated that the AP lengthening induced by low pacing rate was increased when INa,L was 
facilitated with Anemonia toxin (ATX-II). By contrast, inhibition of INa,L with TTX reduced the AP duration 
sensitivity to pacing rate. Based on these data they concluded that INa,L plays a key role in rate 
adaptation of AP duration, conclusion that has been confirmed by others [111, 112]. The involvement of 
late sodium current in rate adaptation could explain why INa,L facilitation caused by mutant sodium 
channel was found to increase the risk for arrhythmias following frequency changes [110].  
The results of Lowe et al. [77] adds support to the connection between INa,L and arrhythmias. Lowe et al. 
reported that INa,L magnitude is higher in female mice compared to males and concluded that this 
difference contributes to higher arrhythmia susceptibility of females.  The increased susceptibility of 
females to arrhythmias may be further compounded by reduced repolarization reserve and larger intra-
myocardial inhomogeneity of calcium and potassium currents in females [113-120]. 
 
4.3. INa,L and calcium homeostasis of cardiac cells 
Sodium channels are cardinal route for Na+ into cardiac cells. In spite of the small magnitude of plateau 
sodium current, there is a consensus that the contribution of the sustained component provides a 
significant fraction (30-50%) of the total sodium entry [3, 6].  It is well documented that INa,L facilitation 
results in increase of cytosolic sodium concentration and it’s specific inhibition can prevent sodium 
accumulation in cardiac myocytes [121-123]. Apart from the impact on the sodium homeostasis of 
cardiac cells, INa,L is implicated in modulation of the calcium homeostasis as well. Increased cytosolic Na+ 
level is translated to elevated cytosolic calcium concentration and known to induce positive inotropic 
response [121, 124].  Calcium homeostasis in linked to INa,L by multiple ways. 
 
4.3.1. INa,L facilitates Ca2+ influx via L-type calcium channels 
As an inward current INa,L lengthens AP and elevates the plateau. The longer depolarization prolongs the 
time while L-type calcium channels remains open and increases the amount of Ca2+ entering to the 
cytoplasm. The profile of L-type calcium current (LTCC) was subject of debate for long time. Model 
studies based on experimental data from traditional voltage clamp experiments employing rectangular 
voltage command predicted divergent dynamics during AP. Some of the models indicated that LTCC is 
present only under early plateau then it declines [125, 126]. According to these models, AP lengthening 
should not alter Ca2+ entry in significant extent. Later, using action potential clamp technique it was well 
documented that LTCC is present during the entire plateau and declines with the terminal repolarization 
in all mammalian models studied [105, 127-130]. Therefore, lengthening the AP adds significant amount 
of Ca2+ to influx via L-type calcium channels. The mechanism what prevent the inactivation of LTCC at 
these positive membrane potential is not completely understood, but reopening of inactivated channels 
has been demonstrated during maintained depolarization [130, 131]. Another possible mechanism for 
sustained LTCC could be the calcium window current. The crossing point for activation and inactivation 
curves is found between -20 and 0 mV allowing a subpopulation of L-type calcium channels to flip-flop 
between open and inactive state [71, 132, 133]. Another mechanism that could maintain LTCC during 
plateau is the non-equilibrium gating mechanism discussed earlier with relation to sustained sodium 
current [2, 18, 19]. However, this possibility has not been tested experimentally. In summary, when INa,L 
prolongs AP, Ca2+ influx is facilitated. 
 
4.3.2. Slip mode conductance: reexamining an old paradigm 
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The Lederer group published an interesting paper in the Science in 1998 where they raised the 
possibility of Ca2+ entry through TTX sensitive sodium channels [134]. They claimed that the selectivity 
of sodium channel can substantially reduce following PKA activation enabling Ca2+ to permeate as 
readily as Na+. The idea was not completely new, Ca2+ permeation through sodium channels in the 
absence of Na+ was reported previously [135]. However, subsequent works produced contradictory 
observations and suggested that TTX sensitive Ca2+ entry following PKA activation involves L-type 
calcium channels but not modulated selectivity of sodium channels [136, 137]. Later, TTX sensitive 
calcium currents were reported from multiple animal models strengthening the evidences against the 
slip mode conductance hypothesis [69, 138-140]. Thus, the slip mode conductance hypothesis has been 
abandoned. Nevertheless, there is a possibility that this mode of Ca2+ entry might need to be revived. It 
has been known for long time that the selectivity of sodium channels is determined by a small number 
of amino acids. In the same time, single mutation in the selectivity filter can decrease the Na+ selectivity 
resulting in a channel permeable for Ca2+ [141-144]. Knowing the increasing number of sodium channel 
mutations [5, 81, 95, 97, 101, 145-147] associated with diverse impact on the electrophysiology and 
deteriorating effects on ionic homeostasis of cardiac myocytes we can postulate that some mutation, 
still not known, might involve altered ion selectivity.  
 
4.3.3. Interaction of INa,L and sodium/calcium exchanger 
The function of NCX in cardiac myocytes is highly complex [148-152]. NCX transports Ca2+ into or out of 
the cell depending on the cell’s thermodynamic state that is the membrane voltage and the gradients of 
Na and Ca2+ across the membrane. Starting at the late systole and through the diastole, NCX removes 
Ca2+ from cytoplasm exchanging it with Na+ (forward mode) [129, 151]. This function is crucial for 
restoration of diastolic Ca2+ level and long term calcium homeostasis. However, when the membrane is 
depolarized and the transient Na current increases the subsarcolemmal Na+ concentration the net 
driving force for the Na+/Ca2+ electrochemical gradient is reversed and NCX transports Ca2+ into the 
cytoplasm while removing Na+ (reverse mode) [129, 151]. Increasing Na+ concentration in the cytoplasm 
shifts the Na+/Ca2+ equilibrium resulting in inhibition of removal and facilitation of calcium entry. The 
mechanism is analogue to the digitalis induced Ca2+ load leading to elevated cytosolic Ca2+ level [149, 
153].  
 
5. Modulation of late sodium current 
The heart adapts to changing conditions, like physical activity, environmental stress or emotional state. 
This adaptation requires moment-to-moment fine tuning of all ion channels and transporters, including 
sodium channels. The sustained component of sodium current is modulated by several physiologic and 
pathologic factor. 
 
5.1. The complex modulation of INa,L by cytosolic Ca
2+  
Ca2+ couples electric signal to contraction machinery in cardiac myocytes and provides an important 
feedback signal to ion channels and pumps of sarcolemma. Voltage gated Na+ channels are known to be 
regulated by Ca2+, calmodulin (CaM) and Ca2+ - CaM dependent protein kinase (CaMK). These 
components modulate INa,L individually and cooperatively [154-156]. Though volume of research data on 
Ca2+ - CaM – CaMK dependent regulation of INa,L, accumulates rapidly, the complex mechanism of this 
function is still not understood due to confliction observations. In spite of contradictory data on the 
individual elements, there is a consensus on that Ca2+ - CaM – CaMK signaling facilitates cardiac sodium 
current, especially the late component [36, 154, 157]. The Ca2+ dependent modulation (both direct and 
indirect) modifies the inactivation of sodium channels. The sodium channel inactivation is a very 
complex process, involving cooperation of multiple distant regions (C-terminus, cytoplasmic linker 
between domain II and IV, and S4-S5 linkers of domains III & IV ) [158]. Ca2+ or CaM binding to this 
region is known to induce a small (5-10 mV) shift in the steady-state inactivation (SSI) curve. Because of 
the steepness of the function and the vicinity of resting membrane potential to the midpoint, relatively 
small changes in voltage sensitivity results in significant impact on the availability of sodium channels 
thus in turn on membrane conductance. Since the membrane potential approaches the sodium 
equilibrium potential when sodium conductivity is maximal, we can assume that any change in sodium 
channel availability has stronger impact on the late than that of transient phase of sodium current. 
There are multiple Ca2+ and CaM binding locations identified between c-terminus and domain III  
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allowing highly complex regulation of channel function. Because of this complexity, mutations in the 
Ca2+ sensing region or pathologic conditions altering the Ca2+ sensitivity may lead diverse functional 
disturbances. 
 
 
Figure 2. 
Schematic representation of the structure of the α-subunit of cardiac sodium channel 
Each domain (DI-DIV) consists of six transmembrane segments (S1-S6) interconnected by intracellular 
and extracellular loops. The intracellular loop between DI-DII is the target region for CaMKII, DIII-DIV 
loop serves as inactivation gate and c-terminus is the Ca2+ and CaM sensor.  
 
 
 
 
5.1.1. Sodium channel and Ca2+  
The most ambiguous part of Ca2+ - CaM – CaMK dependent regulation of INa,L is that whether Ca2+ can 
modulate cardiac sodium channel directly or not. The question was addressed by Wingo et al. in 2004 
and based on their observations they proposed that Ca2+ binds directly to a dedicated motif located 
close to c-terminus and modulates Na+ channel function [159]. This conclusion was supported by several 
experimental data. First, a calcium binding motif (referred as EF hand) known from other Ca2+ regulated 
proteins was identified between domain IV and the CaM binding site in the cardiac sodium channel 
(Figure 2). Second, using NMR spectroscopy it was demonstrated that Ca2+ effectively binds to this EF 
hand. Third, voltage clamp experiments revealed that SSI is shifted toward positive voltages in high 
cytosolic Ca2+ even in the presence of a CaM inhibitor peptide. Furthermore, mutations in the EF hand 
prevented both Ca2+ binding to EF motif and high Ca2+ induced SSI shift. These undeniably consistent 
observations led the authors to the conclusion that Ca2+ exerts direct regulatory effect on sodium 
channel. However, confliction observations from several groups supported that CaM is essential to 
mediate Ca2+ effect and Ca2+ does not regulate sodium channel directly [160, 161]. The most important 
criticism against Wingo and co-workers’ conclusion was that it is not known how effectively the 
inhibitory peptide they used prevents binding of CaM to sodium channels within the cell [158]. To 
resolve the conflicting results reported by so many independent experimenters a new model was 
proposed by Shah et al [162]. According to this model, the sodium channel inactivation is modulated by 
the interaction between Ca2+ binding EF hand and CaM binding IQ motif. In diastolic conditions, CaM 
binds to IQ motif of the c-terminus. When cytosolic Ca2+ concentration is high, CaM binds calcium which 
reduces its affinity to IQ segment. In the next step Ca/CaM detaches from IQ motif enabling it to 
interact with the EF hand, which is the critical step in the model: as it is proposed, binging of IQ motif to 
EF hand increases the calcium affinity of the EF hand by three order of magnitude. Later, Biswas and his 
co-workers confirmed the direct Ca2+ regulation of sodium channels, but using truncated mutants they 
S
1
S
2
S
3
S
4
S
5
S
6
S
1
S
2
S
3
S
4
S
5
S
6
S
1
S
2
S
3
S
4
S
5
S
6 S
1
S
2
S
3
S
4
S
5
S
6
DI DII DIII DIV
EF handIQ motif
CaMKII
- 10 - 
 
have shown that the IQ motif is not essential for the direct Ca2+ regulatory effect [163]. They also 
proposed that CaM-mediated regulation is latent in cardiac sodium channel unless it is unmasked by 
mutations of the EF hand, or very low Ca2+ level in cytoplasm.  
 
5.1.2. Calmodulin 
Calmodulin (CaM) is a ubiquitous calcium sensing protein that mediates Ca2+ effects within wide variety 
of cells, including cardiac myocytes [160, 161]. CaM was shown to interact with the IQ motif of sodium 
channel and regulate gating mechanism [158, 160, 164]. The three dimensional configuration of CaM 
resembles to a dumbbell; the C and N-terminus of the protein forms two globular structures (referred 
as C-lobe and N-lobe respectively) with two calcium binding regions interconnected with a short flexible 
shaft. Each lobe can bind two Ca2+. At physiologically relevant Ca2+ concentrations the Ca2+/CaM 
complex forms a bridge between IQ motif on C-terminus and the DIII-IV linker region [165]. This linker 
region is considered the inactivation gate of sodium channel [166]. When Ca2+ concentration is low and 
CaM does not bind Ca2+ (apo-CaM), the C-lobe is bound to the IQ motif of C-terminus. In this 
configuration, the N-lobe does not interact with the DIII-IV region and inactivation is not affected [162, 
165, 167]. When Ca2+ is elevated, Ca2+/CaM complex (holo-CaM) is formed with different structure and 
affinity for the IQ motif is reduced by a magnitude [162]. There is a switch between C and N-lobes and 
holo-CaM binds to the IQ motif through N-lobe. According to the model proposed by Sarhan et al, C-
lobe can interact with the DIII-IV linker in this configuration and the interaction results in a shift in SSI 
curve to depolarizing direction. These observations indicate that the interaction between the C-lobe of 
holo-CaM and DIII-IV linker is responsible for the altered voltage sensitivity of inactivation [165]. 
Nevertheless, the holo-CaM/DIII-IV interaction is not the only possible mechanism to induce the 
rightward shift of SSI by high Ca2+, because IQ motif deleted sodium channels retain Ca2+ sensitivity 
[163]. As it was discussed above, Ca2+ can bind to the EF-hand of C-terminus altering the voltage 
sensitivity of inactivation too. Parallel to the direct regulation on sodium channel, CaM activates 
Calmodulin Kinase that also modulates the channel kinetics [168].  
 
5.1.3. Calmodulin Kinase   
Cardiac calmodulin kinase is a serine/threonine kinase implicated in a multitude of cellular function in 
vide variety of cells including cardiac myocytes. Cardiac cells express dominantly two isoforms of 
calmodulin kinase type II (CaMKII) referred as nuclear (δB) and cytoplasmic (δC) types; sodium channels 
are regulated by the cytoplasmic isoform [154, 169, 170]. It is now well established that CaMKII 
phosphorylates sodium channels at multiple sites resulting in complex effects and leading to increase of 
INa,L [164, 171, 172]. Generally, upregulation of CaMKII was shown to induce a shift in SSI to depolarizing 
direction, enhance slow or intermediate inactivation and facilitate recovery from inactivation. Each of 
these effects individually and collectively enhance INa,L. While substantial interspecies differences were 
reported on the impact of CaMKII induced phosphorylation on sodium channel gating, the integrated 
effect is always stimulation of the late component of sodium current, and inhibition of the enzyme 
reduces INa,L. Wagner and his co-workers reported negative shift of SSI in rabbit cardiac myocytes 
following overexpression of CaMKII [171]. This observation was confirmed in expression system using 
HEK293 cells by Ashpole et al and Koval et al [172, 173]. In contrast, when Aiba and his co-workers used 
freshly isolated guinea pig ventricular myocytes and CaMKII was added to the pipette solution, they 
observed a positive shift in SSI [164]. Observations regarding the activation of current are discordant 
too. Young and Caldwell reported a hyperpolarizing shift in the voltage dependence of activation [174], 
whereas no effect was seen by others [164, 171, 172, 175]. Aiba et al also reported increased peak 
amplitude for the transient phase of sodium current [164], while others reported no change in this 
parameter [171-173]. There is little information on inactivation of the transient phase of INa. Wagner at 
al. observed significant deceleration of INa decay in the transient phase, but Aiba et al. observed no 
change [164]. Nevertheless, all reports are consistent in that CaMKII enhances the fraction of channels 
undergoing intermediate or slow inactivation. Resultantly, CaMKII upregulation facilitates INa,L that is 
reversible with CaMKII inhibitors. The link between increased CaMKII activity and facilitated INa,L was 
confirmed in both healthy and diseased myocardium by others [157, 176, 177].  
  
5.2. Cellular Metabolism 
Metabolic activity of cardiac myocytes adapts to the momentary changes of the cardiac output, blood 
pressure or autonomic regulation determined by varying environment, physical activity or even 
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emotional state. Cardiac sodium channels has been shown sensitive to the metabolic state of the cell 
and modulated by pH, oxygen or metabolites. During myocardial hypoxia extracellular pH can drop as 
low as 6.0 [178], and cardiac sodium current is known to be modulated by these substantial increase in 
proton concentration [68, 179-182]. There is a consensus on that acidosis reduces the magnitude and 
the decay of the transient phase. Furthermore, positive shift in voltage dependency of activation and 
inactivation was observed in Xenopus expression system [180-182]. Additionally, Jones et al. 
demonstrated an increase in window current and deceleration of time constant of slow inactivation in 
Xenopus oocytes. Based on these data they predicted AP lengthening at low pH in a computer model 
[180]. Murphy et al. reported depolarizing shift in voltage dependency of activation, but not in SSI in 
freshly isolated canine ventricular myocytes [68, 179]. In agreement with Jones et al., they observed the 
prolongation of AP at low pH, but they found that INa,L was reduced at in both endocardial and epicardial 
cells [68].  
Acute and chronic hypoxia is known to induce electric disturbances in myocardium leading to 
arrhythmia. Several study addressed the effect of hypoxia on INa,L and all observations, employing wide 
variety of experimental model consistently showed that hypoxia increases the late sodium current [11, 
183-187]. Wang et al. studied the mechanism of hypoxia induced INa,L facilitation [183]. Recording single 
channel current they found increased burst mode activity following 15 minutes hypoxia that may 
explain the increased persistent sodium current. They also reported hyperpolarizing shift in SSI curve 
resulting in significant reduction of transient INa and probably attenuating hypoxia induced facilitation of 
INa,L due to reduced window current. Interestingly, Wang et al. found that hypoxia shortens AP duration 
in spite of increased INa,L which indicate that other hypoxia sensitive ion channel(s) also contribute to 
shaping AP in cardiac cells.  
Hydrogen peroxide and free radicals were demonstrated to stimulate INa,L by several team [122, 188-
190]. In accordance with these observations, specific INa,L inhibitor ranolazine or TTX attenuated the AP 
lengthening effect of H2O2 [190]. However, Erickson and his co-workers showed that free radicals can 
directly activate CaMKII [191]; therefore CaMKII might be involved in INa,L facilitation in the presence of 
free radicals.  
INa,L is modulated by wide variety of metabolites and second messengers. Poly-unsaturated fatty acids, 
like docosahexaenoic and eicosapentaenoic acids (DHA, EPA) were shown to substantially reduce both 
transient and late phase of INa [192]. The reduction develops from hyperpolarizing shift in SSI and 
activation curve decreasing the window current. An ischemic metabolite, lysophosphatidylcholine was 
also demonstrated to reduce transient INa, but effects on INa,L has not been addressed in these studies 
[12, 193]. Nitrogen oxide was found to facilitate INa,L by Ahern and co-workers fifteen years ago; they 
proposed that nitrosylation of sodium channels within its own plasma membrane modify the gating of 
cardiac sodium channel [194]. Since then the mechanism has been confirmed by Cheng et al. 
demonstrating that caveolin-3 as mediates sodium channel nitrosylation [195]. 
 
5.3. Mechanical stress 
Myocardial wall tension is subject of moment to moment change during cardiac cycle and ion channels 
embedded into the cell membrane experience variable mechanical stress. It is now well established that 
cardiac sodium channels respond to mechanical stress with altered gating function [49, 196]. Beyder et 
al. investigated the mechanosensitivity of Nav 1.5 in expression model using cell-attached patch clamp 
configuration and characterized the stretch induced modulation of INa [49]. Increased stretch of the 
patch resulted in a negative shift in both SSI and activation curve and decelerated recovery from 
inactivation. Interestingly, the membrane stress increased the number of available channels under the 
patch, leading to increase in peak current. Recently, the same group confirmed these observations on 
freshly isolated mouse ventricular cells [197]. Moreover, in the same publication authors demonstrated 
that ranolazine inhibits the mechanosensitivity of cardiac sodium channels on dose dependent manner. 
Further supporting evidences on inhibitory effect of Ranolazine on mechanosensitivity of Nav 1.5  has 
been obtained in cultured atrial myocytes and published from the same team subsequently [198]. 
Ranolazine is antiarrhythmic drug known to target cardiac sodium channels and inhibiting INa,L with high 
selectivity over INa,T [43, 51, 123, 199, 200]. Considering that myocardial wall stretch is known to play 
key role in arrhythmogenesis [201-203] these data may establish a new therapeutic strategy in 
antiarrhythmic pharmacology. Currently, pharmacological reduction of preload with diuretics and 
vasodilators is the only possibility to reduce wall stress and prevent disease progression in 
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arrhythmogenic right ventricular cardiomyopathy [204, 205]. Reducing mechanical sensitivity of the 
electric system in cardiac myocytes might open a new direction. 
 
6. The plateau sodium current in heart diseases 
It is now well established that the upregulation of INa,L results in pathologic cardiac function including 
contractile dysfunction, arrhythmia and structural heart disease [5, 6, 41, 44, 57, 77, 100]. There are 
several conditions (mutation, hypoxia, ischemia, carbon monoxide, CaMKII or angiotensin II activation, 
etc.) known to facilitate INa,L and leading to cardiac dysfunction [6]. The impact of the sustained sodium 
current on cardiac function is complex. The current flowing through sodium channels during plateau is 
very small relative to the currents causing either the upstroke or terminal repolarization of AP. 
However, to understand the functional relevance of INa,L in cardiac function it is important to understand 
that (1) other currents flowing under the plateau have very low magnitude as well, therefore the 
contribution of INa,L to the profile of plateau is significant. Furthermore, (2) sodium channels are the 
major route for sodium into the cell. The transient phase of INa is short with high peak; the majority (90-
95%) of sodium ions passes the membrane in less than 5 ms. In contrast to that, the magnitude of the 
sustained part is less than 1% of the peak lasting for several hundred ms. Thus, in spite of the 
remarkable difference in the magnitude, the amount of sodium entering into the cardiac myocytes 
during the transient and sustained phase of INa are comparable [206, 207].  
 
6.1. INa,L and the ion homeostasis of cardiac cells 
Plateau sodium current adds substantial amount of sodium to the total entry during electric cycle. 
When INa,L is enhanced, Na+ influx can be increased several fold resulting in increased cytosolic sodium 
concentration. Sodium is extruded from the cells by Na+/K+-ATPase (NKA) with stoichiometry of 3/2 
using one ATP molecule in each pump cycle. The KD for ATP and potassium are 1-2 mM and 80-150 µM 
respectively; therefore, ATP or extracellular K+ concentration is not a limiting factor for NKA activity, 
because intracellular ATP and extracellular K+ concentrations are significantly higher than these values 
[150]. In contrast to these, the KD for Na+ is in the range of 10-20 mM and the intracellular Na+ 
concentration falls to the range of 5-15 mM resulting in high sodium sensitivity for NKA. Thus, increasing 
cytosolic Na+ concentration stimulates NKA and increases ATP catabolism. Considering that, INa,L 
upregulation often coincide with ischemic/hypoxic conditions, the increased ATP utilization can worsen 
the energetic state of cardiac myocytes depleting the ATP pools of the cell. Besides, experimental 
observations indicate that, in spite of the facilitation, NKA cannot keep cytosolic sodium concentration 
in the normal range and increased INa,L results in elevated cytosolic Na+ concentration [121, 122]. 
Elevated cytosolic sodium concentration shifts the equilibrium potential for Na+/Ca2+ exchanger 
facilitating reverse mode and inhibiting forward mode; hence, some of the extra sodium entered is 
converted to calcium [70, 149, 150, 208, 209]. Ca2+ is the key regulator of the majority of functions in 
cardiac myocytes, including metabolism, electric activity, contractility as well as apoptosis [154, 169, 
170, 209-212]. Elevated cytosolic calcium leads to Ca2+ overload in sarcoplasmic reticulum resulting in 
contractile dysfunction and increased risk for arrhythmia [51, 213-217]. 
 
6.2. Role of INa,L in arrhythmogenesis 
Acquired or inherited increase of  INa,L is associated with enhanced risk for cardiac arrhythmia and 
inhibition of INa,L was demonstrated to prevent or abolish arrhythmic electric activity of the heart [1, 3, 
5, 6, 41, 57, 123, 214, 215]. There are multiple mechanisms INa,L might lead to manifest arrhythmic 
activity.  
First, increase of any inward current – like INa,L – during the plateau can cause AP prolongation, 
increasing the risk for early afterdepolarizations (EAD). EADs are documented to occur more frequently 
at long AP duration resulted from either increased inward or decreased outward currents. EADS are 
slow membrane potential oscillations due to reactivation of inward currents during phase two and three 
of AP and implicated in triggered arrhythmias [218, 219]. The possible candidates for the reactivating 
currents are ICa,L, INa,L, and INCX. I has been postulated that augmentation of ICa,L or INa,L occurs by window 
mechanism [9, 96, 133]. Calcium overload was documented also to promote the generation of EAD but 
the mechanism is not completely understood [220, 221]. However, it has been proposed that 
spontaneous calcium release from sarcoplasmic reticulum might facilitate INCX and induce membrane 
oscillations [133, 218, 220, 221]. Horvath and his co-workers recently investigated the role of INa,L in 
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generation of EAD [20]. They showed that facilitation of INa,L  by Anemone toxin II prolonged APD and 
induced Ca2+ oscillations that led to EADs, but  these arrhythmogenic activities were eliminated by 
buffering cytosolic Ca2+  with BAPTA. From these observations they concluded that INa,L may contribute 
to AP prolongation that favors the generation of EAD, but membrane oscillation arise from 
augmentation of INCX due to cytosolic calcium oscillations. 
Second, upregulation of INa,L was shown to facilitate generation of spontaneous depolarizations 
developing at resting membrane potential (between two APs) and referred as delayed 
afterdepolarizations (DAD)  [38, 222]. There is a consensus opinion on that DADs arise from 
spontaneous calcium release from the sarcoplasmic reticulum that facilitate INCX, a similar mechanism 
discussed previously with regard to EADs [223-226]. In this sense, INa,L does not provide the depolarizing 
power for the depolarization, but inducing calcium overload ‘set the stage’ for spontaneous cytoplasmic 
Ca2+ oscillations [6]. 
Third, an increase of INa,L is known to facilitate beat to beat variability and regional inhomogeneity of AP 
duration [8, 84, 189, 227, 228]. Increased beat to beat variability results from reduced repolarization 
reserve and makes the heart more vulnerable to potentially proarrhythmic prolongation of the APD 
[229]. Regional differences in AP duration are generally attributed to asymmetrical distribution of 
various ion channels [105, 230-235]. The transmural heterogeneity of INa,L was discussed previously.  
Increase in both beat to beat variability and transmural heterogeneity may result in increased 
prevalence of cardiac arrhythmias due to increased dispersion under certain (usually pathological) 
conditions [236, 237]. 
 
6.3. INa,L and structural heart disease 
The most argued cardiac disorder linked to INa,L is dilated cardiomyopathy (DCM) a progressive structural 
heart disease characterized by reduced myocardial force generation and enlarged chambers. In spite of 
the increasing volume of evidence that links SCN5A mutations to DCM, the mechanism how a defective 
ion channel function leads to structural disease remains unclear. The first observations that associated 
DCM to SCN5A mutation was published in 2004 and 2005 from two different groups [99, 238]. The 
strikingly new hypothesis that sodium channel gene mutation may lead to structural heart disease was 
challenged by Groenewegen & Wilde suggesting the role of another gene, different from SCN5A in DCM 
phenotype [239]. In the following years new SCN5A mutations were identified in DCM patients 
providing further evidence that sodium chanellopathy can be associated with structural heart disease 
[101, 240]. In 2012 Gosselin-Badaroudine and his coworkers have shown that the mutation in these 
sodium channels resulted in a proton leak through an alternative pore not related to the Na+ path [241]. 
They proposed that acidification of cardiac myocytes may cause the DCM phenotype of these patients.  
 
7. The plateau sodium current as therapeutic target 
Several compounds are known to increase or inhibit INa,L, and a few of them are employed in clinical 
practice as antiarrhythmic drug. Compounds known to facilitate late sodium current are used 
exclusively as pharmacological tool for research because they promote arrhythmogenesis that prevents 
their clinical application [1, 2]. The most frequently used INa,L activators seen in research papers are 
Veratridine and  Sea Anemone Toxin (ATX-II); ATX-II is more specific than Veratridin [20, 121, 123]. 
Other activators like ouabaine or Pyrethroids are also used for research purposes but held more ‘dirty’ 
[6, 121]. 
Pharmacological suppression of plateau sodium current was shown beneficial to reduce contractile 
dysfunction and arrhythmic activity in several pathologic model [45, 197, 214, 242-245]. Since INa,L is the 
non-inactivating component of INa,T, it is inhibited by sodium channel blockers including quinidine, 
mexiletine or local anesthetics like lidocaine. It is very likely that beneficial effects of traditional Class I 
sodium channel blockers are exerted via INa,L inhibition. However, Class I drugs display strong 
proarrhythmic effects and increase mortality; this led to the opinion that treatment of arrhythmias with 
sodium channel blockers is harmful. Thus, research has shifted toward selective INa,L blockers with no 
inhibitory effect on INa,T. Some of the classic sodium channel inhibitors including lidocaine, mexiletine or 
flecainide (Figure 3.) display 5-10-fold INa,L selectivity over INa,T (see Table 1), but these drugs significantly 
suppress conductivity in the therapeutic range promoting reentry type arrhythmia [246-248]. Mixed ion 
channel blocker amiodarone has outstanding INa,L/INa,T selectivity amongst traditional antiarrhythmic 
drugs [249], but chronic amiodarone is documented to carry severe side effects preventing its use in 
long term therapy [250-259].  
- 14 - 
 
 
 
Figure 3.  
Chemical structures of INa,L inhibitors.  
 
 
 
The first, highly selective INa,L blocker with no known adverse effects was Ranolazine, an anti-ischemic, 
antianginal drug [244, 245]. Ranolazine (Figure 3) effectively inhibits late sodium current with 17 and 
1300 µM EC50 for INa,L and INa,T respectively [123]. Apart from the primary INa,L inhibitory effect, 
Ranolazine was also demonstrated to decrease calcium overload, improve mechanical dysfunction and 
reduce mechanosensitivity of sodium channel [197, 198, 214]. However, Ranolazine reduces IKr, INCX and 
ICa,L with EC50 value between 12-90 µM and blocks catecholamine receptors too [260, 261]. The success 
of Ranolazine stimulated research to develop highly selective INa,L blockers with less side effects (see 
Table 1). Recently a new promising molecule, compound GS967 (Figure 3) was shown to attenuate 
ischemia and methoxamine-clofilium induced arrhythmia in rabbit. GS967 is more potent and effective 
inhibitor for INa,L than Ranolazine with higher EC50 for IKr [123].  
An interesting work was published in 2013 by an international team in PACE [262]. Xue at al. studied the 
effect of a Chinese herb extract, Wenxin Keli on ventricular arrhythmias in rabbit model. Wenxin Keli is 
used in traditional medicine as treatment for angina and various arrhythmias. Authors showed in their 
paper that Wenxin Keli suppresses afterdepolarizations and inhibits INa,L in dose dependent manner. 
However, the specific component of the extract responsible for the beneficial effects is not identified. 
 
 
 
 
 
 
  
O
S
N
H
S
R1 O
(R) (S)
F
O
N N
N
H
O
O
O
N
AZD1305
F15845
N
S
N
O N OCH3
OCH3
CH3
KC 12291
O
N
H
N
CH3N
SF
R 56865
O
I
I
O
N
O Amiodarone
N
N
O
H
H
H H
Sophocarpine
N
N
N
O
F
F
F
F
F
F
GS967
OO
O
N
OH
Vernakalant
OH
OH
HO
Resveratrol
H
N
O
N
N
OH
O
O
Ranolazine
N
H
O
H
N
OF
F F
OF
FF
Flecainide
O
NH2
Mexiletine
- 15 - 
 
 
Table I. List of pharmacons reported to inhibit INa,L  
 
Name EC50 Effective cc. Selectivity 
AZD1305 4.3 µM [263]  EC50 for INa,T: 66 µM [263] 
F15845 5.3 µM [264]   
GS967 0.13 µM [123]  INa,T: 7.5% inhibition at 10 µM [123] 
KC 12291 9.6 µM [265]  25% IK1 inhibition at 10 µM;  
42% Ito inhibition at 10 µM [266] 
R 56865 200 nM [267]  Binds to α1-adrenoceptors, 5-HT 
receptors, DHP receptors with Ki 
between 20-340 nM [268] 
RSD1235 
(Vernakalant) 
31 µM [269] 30 nM [270] EC50 for Kv1.5, Kv4.2 and Kv4.3: 
between 10-40 µM; IK1: 1 mM; ICa,L: 220 
µM [269] 
Amiodarone 6.7 µM [249]  EC50 for INa,T: 87 µM [249]; 
IKr: 2.8 µM [271]. Inhibits IK1 and IKs in 
concentration higher than 10 µM [272, 
273]  
Flecainide 3.4 µM [123]  EC50 for INa,T: 84 µM  [123] 
Mexiletine 18 µM [274]  EC50 for INa,T: 35 µM; 
No effect on ICa,L up to 100 µM [274] 
Ranolazine 17 µM [123] 
  6 µM [199]  
 EC50 for INa,T: 1329 µM  [123]; 
EC50 for IKr : 12 µM, INCX : 91 µM, ICa,L : 50 
µM [199] 
Resveratrol 34 µM [275]   
Sophocarpine  30 µM [276] 
20-80 µM [215] 
Inhibits INCX in concentrations higher 
than 20 µM [215] 
Wenxin Keli 4 µM [262]  EC50 for INa,T: 11 µM [262] 
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